,Drug Name,SpMAX4_Bh(s),NHISS,Experimental Category,SpMAX4_Bh(s) Analysis Group,NHISS Analysis Group1,Venetoclax,7,5,1,training,training2,Docetaxel,7.43,5,1,training,training3,Paclitaxel,7.43,6,1,training,training4,Trametinib,7.43,5,1,training,training5,Enzalutamide,8,6,1,training,training6,Sorafenib,7.43,5,1,training,training7,Fulvestrant,8,7,1,training,training8,Rapamycin,7.42,5,1,training,training9,Silvesterol,4.97,1,0,training,training10,Erlotinib,4.67,0,0,training,training11,Idelalisib,4.83,2,0,training,training12,Camptotecin,4.99,2,0,training,training13,Selumetinib,5,2,0,training,training14,Sunitinib,4.82,3,0,training,training15,Taselisib,4.89,1,0,training,training16,Lapatinib,5.12,3,0,training,training17,Avagacestat,8,7,1,validation,training18,Dutasteride,8,8,1,validation,training19,Regorafenib,8,6,1,validation,training20,RO4929097,8,8,1,validation,training21,TAK-632,8,6,1,validation,training22,Celecoxib,7.73,5,1,validation,training23,Dabrafenib,7.72,5,1,validation,training24,Valrubicin,7.44,8,1,validation,training25,Nilotinib,7.43,4,1,validation,training26,Pluripotin,7.43,5,1,validation,training27,Vemurafenib,7.43,5,1,validation,training28,Everolimus,7.42,5,1,validation,training29,Tanespimycin,7.42,4,1,validation,training30,BMS-777607,7.41,4,1,validation,training31,Glimepiride,7.41,5,1,validation,training32,Tacrolimus,7.35,4,1,validation,training33,ABT737,7,5,1,validation,training34,Glibenclamide,7,4,1,validation,training35,Binimetinib,6.46,3,0,validation,training36,Forskolin,6.44,2,0,validation,training37,Luminespib,5.19,1,0,validation,training38,Talazoparib,5.07,3,0,validation,training39,Apitolisib,5.01,1,0,validation,training40,Pazopanib,4.98,2,0,validation,training41,Ipatasertib,4.93,1,0,validation,training42,Dactolisib,4.93,1,0,validation,training43,ZSTK474,4.91,2,0,validation,training44,MGCD-265,4.9,2,0,validation,training45,Valdecoxib,4.83,2,0,validation,training46,Gefitinib,4.76,1,0,validation,training47,Panobinostat,4.76,1,0,validation,training48,INK128,4.75,0,0,validation,training49,AZD-4547,4.72,1,0,validation,training50,Voxtalisib,4.62,1,0,validation,training51,Verapamil,4.5,0,0,validation,training52,Terbinafine,4.29,0,0,validation,training53,Selumetinib,5,2,,?,?